A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
Clinical trial NCT06155396 · RECRUITING
Trial details
- NCT number
- NCT06155396
- Sponsor
- RemeGen Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-11
- Primary completion
- 2027-06-30
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.